These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expression of MLR-S in human myeloid, monocytic and erythroid cell differentiation. Han T; Minowada J J Clin Lab Immunol; 1980 Nov; 4(3):169-73. PubMed ID: 6451711 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of gamma-glutamyl transpeptidase activity at the surface of human myeloid cells is correlated with macrophage maturation and transforming growth factor beta production. Bauvois B; Laouar A; Rouillard D; Wietzerbin J Cell Growth Differ; 1995 Sep; 6(9):1163-70. PubMed ID: 8519693 [TBL] [Abstract][Full Text] [Related]
24. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). Fibach E; Peled T; Rachmilewitz EA J Cell Physiol; 1982 Oct; 113(1):152-8. PubMed ID: 6957411 [TBL] [Abstract][Full Text] [Related]
25. Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium. Dayton ET; Perussia B; Trinchieri G J Immunol; 1983 Mar; 130(3):1120-8. PubMed ID: 6185572 [TBL] [Abstract][Full Text] [Related]
26. Differentiation of human leukemic cell lines (HL60, U937) toward macrophages is accompanied by production of colony-stimulating activity (CSA). Ascensao JL; Mickman JK Exp Hematol; 1984 Mar; 12(3):177-82. PubMed ID: 6608453 [TBL] [Abstract][Full Text] [Related]
27. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines. Dawson MJ; Trapani JA J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752 [TBL] [Abstract][Full Text] [Related]
29. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation. Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259 [TBL] [Abstract][Full Text] [Related]
30. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter. Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202 [TBL] [Abstract][Full Text] [Related]
31. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells. Schwartz EL; Blair OC; Sartorelli AC Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046 [TBL] [Abstract][Full Text] [Related]
32. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928 [TBL] [Abstract][Full Text] [Related]
34. Behavior in vitro of long-term cultured bone marrow or blood cells from chronic myeloid leukemia: adhesion molecules and differentiation antigens as detected by immunocytochemistry. Pasternak G; Pasternak L Folia Biol (Praha); 1994; 40(6):439-54. PubMed ID: 7589702 [TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines. Schwartz EL; Sartorelli AC Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957 [TBL] [Abstract][Full Text] [Related]
36. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells. Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684 [TBL] [Abstract][Full Text] [Related]
37. Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias. Drexler HG; Menon M; Klein M; Bhoopalam N; Messmore HL; Minowada J Clin Exp Immunol; 1986 Aug; 65(2):363-72. PubMed ID: 3466728 [TBL] [Abstract][Full Text] [Related]
38. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage. Briggs R; Dworkin L; Briggs J; Dessypris E; Stein J; Stein G; Lian J J Cell Biochem; 1994 Feb; 54(2):198-206. PubMed ID: 8175894 [TBL] [Abstract][Full Text] [Related]
39. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase. Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523 [TBL] [Abstract][Full Text] [Related]
40. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]